References ASCO 2023

View our sources.

#CitationLinkSource
1Cancino RS, Su Z, Mesa R, Tomlinson GE, Wang J. The Impact of COVID-19 on Cancer Screening: Challenges and Opportunities. JMIR Cancer. 2020 Oct 29;6(2):e21697. doi: 10.2196/21697. PMID: 33027039; PMCID: PMC7599065. View JMIR Cancer
2Pashayan N, Morris S, Gilbert FJ, Pharoah PDP. Cost-effectiveness and Benefit-to-Harm Ratio of Risk-Stratified Screening for Breast Cancer: A Life-Table Model. JAMA Oncol. 2018 Nov 1;4(11):1504-1510. doi: 10.1001/jamaoncol.2018.1901. Erratum in: JAMA Oncol. 2022 Mar 1;8(3):484. PMID: 29978189; PMCID: PMC6230256. View JAMA Oncology
3Jayasekera J, Mandelblatt JS. Systematic Review of the Cost Effectiveness of Breast Cancer Prevention, Screening, and Treatment Interventions. J Clin Oncol. 2020 Feb 1;38(4):332-350. doi: 10.1200/JCO.19.01525. Epub 2019 Dec 5. PMID: 31804858; PMCID: PMC6994253. View Journal of Clinical Oncology
4 Breast Cancer Screening in Women at Higher-Than-Average Risk: Recommendations From the ACR. Monticciolo, Debra L. et al. Journal of the American College of Radiology, Volume 15, Issue 3, 408 – 414 . https://www.jacr.org/article/S1546-1440(17)31524-7/fulltext View American College of Radiology
5 Breast cancer risk assessment tool SAS MACRO (Gail Model). National Cancer Institute. 2018. Retrieved September 21, 2022, from https://dceg.cancer.gov/tools/risk-assessment/bcrasasmacro View National Cancer Institute

Last Updated

 

Information on this page was last updated on May 12, 2023.

 

Empower yourself and find your risk of breast cancer.

Use your smartphone or our website to calculate your personalized risk of breast cancer and find out if you may qualify for earlier breast cancer screening.

Skip to content